Neuroprotectants: Reactive Oxygen Species (ROS) Based

E. D. Hall

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review


Reactive oxygen species (ROS)-induced membrane lipid peroxidation (LP) is clearly one of the best validated secondary injury mechanisms in preclinical focal ischemic stroke and subarachnoid hemorrhage (SAH) models. Two main sources of LP-initiating free radicals are ferrous iron (Fe2+)-driven Fenton reactions, which give rise to the highly reactive hydroxyl radical (OH), and the reactive nitrogen species peroxynitrite (ONOO-), which can similarly generate OH and the equally reactive nitrogen dioxide (NO2) and carbonate (CO3) radicals. After initiation of LP by these potent ROS, the process propagates through the membrane disrupting phospholipid structure and impairing the function of membrane-localized proteins. In addition, peroxidation of the LP-susceptible polyunsaturated fatty acids results in the formation of neurotoxic aldehyde-containing products, such as 4-hydroxynonenal (4-HNE) and 2-propenal (acrolein) that bind to cellular proteins, impairing their normal functions and leading to generation of additional ROS. This chapter summarizes the progress over the years with regard to the preclinical discovery and attempted clinical development of antioxidant drugs for focal ischemic stroke and SAH, as well as newer ROS-based pharmacologic strategies.

Original languageEnglish
Title of host publicationPrimer on Cerebrovascular Diseases
Subtitle of host publicationSecond Edition
Number of pages6
StatePublished - Mar 7 2017

Bibliographical note

Publisher Copyright:
© 2017 Elsevier Inc. All rights reserved.


  • 4-Hydroxynonenal
  • Acrolein
  • Antioxidants
  • Carbonyl scavengers
  • Free radical scavengers
  • Lipid peroxidation
  • Neuroprotection
  • Reactive oxygen species

ASJC Scopus subject areas

  • General Neuroscience


Dive into the research topics of 'Neuroprotectants: Reactive Oxygen Species (ROS) Based'. Together they form a unique fingerprint.

Cite this